The World Health Organisation (WHO) has reported an increase in cholera cases, with 473,000 cases recorded in 2022, twice the figure in 2021. In a statement, yesterday, WHO disclosed that an estimated increase of 700,000 cases was projected for 2023, emphasising the urgent need for effective interventions.

The new prequalification is hoped to enable a rapid increase in production and supply which many communities battling with cholera outbreaks urgently need.

The global health body added that the prequalification list already includes Euvichol and Euvichol-Plus inactivated oral cholera vaccines produced by EuBiologicals Co., Ltd, Republic of South Korea, which also produces the new vaccine Euvichol-S.  

It reads further: Vaccines provide the fastest intervention to prevent, limit and control cholera outbreaks but supplies have been at the lowest point amidst countries facing dire shortcomings in other areas of cholera prevention and management such as safe water, hygiene and sanitation. 

You must be logged in to post a comment.

Why are you flagging this comment?

I disagree with this user

Targeted harassment - posted harassing comments or discussions targeting me, or encouraged others to do so

Spam - posted spam comments or discussions

Inappropriate profile - profile contains inappropriate images or text

Threatening content - posted directly threatening content

Private information - posted someone else''s personally identifiable information

Before flagging, please keep in mind that Disqus does not moderate communities. Your username will be shown to the moderator, so you should only flag this comment for one of the reasons listed above.

We will review and take appropriate action.

Get the latest news delivered straight to your inbox every day of the week. Stay informed with the Guardians leading coverage of Nigerian and world news, business, technology and sports.

Follow Us